Structure-Based Design and Synthesis of Apramycin–Paromomycin Analogues: Importance of the Configuration at the 6′-Position and Differences between the 6′-Amino and Hydroxy Series
The preparation of a series of four analogues of the aminoglycoside antibiotics neomycin and paromomycin is described in which ring I, involved in critical binding interactions with the ribosomal target, is replaced by an apramycin-like dioxabicyclo[4.4.0]octane system. The effect of this modificat...
Saved in:
Published in | Journal of the American Chemical Society Vol. 139; no. 41; pp. 14611 - 14619 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
WASHINGTON
American Chemical Society
18.10.2017
Amer Chemical Soc |
Subjects | |
Online Access | Get full text |
ISSN | 0002-7863 1520-5126 1520-5126 |
DOI | 10.1021/jacs.7b07754 |
Cover
Abstract | The preparation of a series of four analogues of the aminoglycoside antibiotics neomycin and paromomycin is described in which ring I, involved in critical binding interactions with the ribosomal target, is replaced by an apramycin-like dioxabicyclo[4.4.0]octane system. The effect of this modification is to lock the hydroxymethyl side chain of the neomycin or paromomycin ring I, as part of the dioxabicyclooctane ring, into either the gauche–gauche or the gauche–trans conformation (respectively, axial or equatorial to the bicyclic system). The antiribosomal activity of these compounds is investigated with cell-free translation assays using both bacterial ribosomes and recombinant hybrid ribosomes carrying eukaryotic decoding A site cassettes. Compounds substituted with an equatorial hydroxyl or amino group in the newly formed ring are considerably more active than their axial diastereomers, lending strong support to crystallographically derived models of aminoglycoside–ribosome interactions. One such bicyclic compound carrying an equatorial hydroxyl group has activity equal to that of the parent yet displays better ribosomal selectivity, predictive of an enhanced therapeutic index. A paromomycin analog lacking the hydroxymethyl ring I side chain is considerably less active than the parent. Antibacterial activity against model Gram negative and Gram positive bacteria is reported for selected compounds, as is activity against ESKAPE pathogens and recombinant bacteria carrying specific resistance determinants. Analogues with a bicyclic ring I carrying equatorial amino or hydroxyl groups mimicking the bound side chains of neomycin and paromomycin, respectively, show excellent activity and, by virtue of their novel structure, retain this activity in strains that are insensitive to the parent compounds. |
---|---|
AbstractList | The preparation of a series of four analogues of the aminoglycoside antibiotics neomycin and paromomycin is described in which ring I, involved in critical binding interactions with the ribosomal target, is replaced by an apramycin-like dioxabicyclo[4.4.0]octane system. The effect of this modification is to lock the hydroxymethyl side chain of the neomycin or paromomycin ring I, as part of the dioxabicyclooctane ring, into either the gauche-gauche or the gauche-trans conformation (respectively axial or equatorial to the bicyclic system). The antiribosomal activity of these compounds is investigated with cell-free translation assays using both bacterial ribosomes and recombinant hybrid ribosomes carrying eukaryotic decoding A site cassettes. Compounds substituted with an equatorial hydroxyl or amino group in the newly formed ring are considerably more active than their axial diastereomers, lending strong support to crystallographically-derived models of aminoglycoside-ribosome interactions. One such bicyclic compound carrying an equatorial hydroxyl group has activity equal to that of the parent, yet displays better ribosomal selectivity, predictive of an enhanced therapeutic index. A paromomycin analog lacking the hydroxymethyl ring I side chain is considerably less active than the parent. Antibacterial activity against model Gram negative and Gram positive bacteria is reported, for selected compounds, as is activity against ESKAPE pathogens and recombinant bacteria carrying specific resistance determinants. Analogues with a bicyclic ring I carrying equatorial amino or hydroxyl groups mimicking the bound side chains of neomycin and paromomcyin, respectively, show excellent activity and, by virtue of their novel structure, retain this activity in strains that are insensitive to the parent compounds. The preparation of a series of four analogues of the aminoglycoside antibiotics neomycin and paromomycin is described in which ring I, involved in critical binding interactions with the ribosomal target, is replaced by an apramycin-like dioxabicyclo[4.4.0]octane system. The effect of this modification is to lock the hydroxymethyl side chain of the neomycin or paromomycin ring I, as part of the dioxabicyclooctane ring, into either the gauche-gauche or the gauche-trans conformation (respectively, axial or equatorial to the bicyclic system). The antiribosomal activity of these compounds is investigated with cell-free translation assays using both bacterial ribosomes and recombinant hybrid ribosomes carrying eukaryotic decoding A site cassettes. Compounds substituted with an equatorial hydroxyl or amino group in the newly formed ring are considerably more active than their axial diastereomers, lending strong support to crystallographically derived models of aminoglycoside-ribosome interactions. One such bicyclic compound carrying an equatorial hydroxyl group has activity equal to that of the parent yet displays better ribosomal selectivity, predictive of an enhanced therapeutic index. A paromomycin analog lacking the hydroxymethyl ring I side chain is considerably less active than the parent. Antibacterial activity against model Gram negative and Gram positive bacteria is reported for selected compounds, as is activity against ESKAPE pathogens and recombinant bacteria carrying specific resistance determinants. Analogues with a bicyclic ring I carrying equatorial amino or hydroxyl groups mimicking the bound side chains of neomycin and paromomycin, respectively, show excellent activity and, by virtue of their novel structure, retain this activity in strains that are insensitive to the parent compounds. The preparation of a series of four analogues of the aminoglycoside antibiotics neomycin and paromomycin is described in which ring I, involved in critical binding interactions with the ribosomal target, is replaced by an apramycin-like dioxabicyclo[4.4.0]octane system. The effect of this modification is to lock the hydroxymethyl side chain of the neomycin or paromomycin ring I, as part of the dioxabicyclooctane ring, into either the gauche–gauche or the gauche–trans conformation (respectively, axial or equatorial to the bicyclic system). The antiribosomal activity of these compounds is investigated with cell-free translation assays using both bacterial ribosomes and recombinant hybrid ribosomes carrying eukaryotic decoding A site cassettes. Compounds substituted with an equatorial hydroxyl or amino group in the newly formed ring are considerably more active than their axial diastereomers, lending strong support to crystallographically derived models of aminoglycoside–ribosome interactions. One such bicyclic compound carrying an equatorial hydroxyl group has activity equal to that of the parent yet displays better ribosomal selectivity, predictive of an enhanced therapeutic index. A paromomycin analog lacking the hydroxymethyl ring I side chain is considerably less active than the parent. Antibacterial activity against model Gram negative and Gram positive bacteria is reported for selected compounds, as is activity against ESKAPE pathogens and recombinant bacteria carrying specific resistance determinants. Analogues with a bicyclic ring I carrying equatorial amino or hydroxyl groups mimicking the bound side chains of neomycin and paromomycin, respectively, show excellent activity and, by virtue of their novel structure, retain this activity in strains that are insensitive to the parent compounds. The preparation of a series of four analogues of the aminoglycoside antibiotics neomycin and paromomycin is described in which ring I, involved in critical binding interactions with the ribosomal target, is replaced by an apramycin-like dioxabicyclo[4.4.0]octane system. The effect of this modification is to lock the hydroxymethyl side chain of the neomycin or paromomycin ring I, as part of the dioxabicyclooctane ring, into either the gauche-gauche or the gauche-trans conformation (respectively, axial or equatorial to the bicyclic system). The antiribosomal activity of these compounds is investigated with cell-free translation assays using both bacterial ribosomes and recombinant hybrid ribosomes carrying eukaryotic decoding A site cassettes. Compounds substituted with an equatorial hydroxyl or amino group in the newly formed ring are considerably more active than their axial diastereomers, lending strong support to crystallographically derived models of aminoglycoside-ribosome interactions. One such bicyclic compound carrying an equatorial hydroxyl group has activity equal to that of the parent yet displays better ribosomal selectivity, predictive of an enhanced therapeutic index. A paromomycin analog lacking the hydroxymethyl ring I side chain is considerably less active than the parent. Antibacterial activity against model Gram negative and Gram positive bacteria is reported for selected compounds, as is activity against ESKAPE pathogens and recombinant bacteria carrying specific resistance determinants. Analogues with a bicyclic ring I carrying equatorial amino or hydroxyl groups mimicking the bound side chains of neomycin and paromomycin, respectively, show excellent activity and, by virtue of their novel structure, retain this activity in strains that are insensitive to the parent compounds.The preparation of a series of four analogues of the aminoglycoside antibiotics neomycin and paromomycin is described in which ring I, involved in critical binding interactions with the ribosomal target, is replaced by an apramycin-like dioxabicyclo[4.4.0]octane system. The effect of this modification is to lock the hydroxymethyl side chain of the neomycin or paromomycin ring I, as part of the dioxabicyclooctane ring, into either the gauche-gauche or the gauche-trans conformation (respectively, axial or equatorial to the bicyclic system). The antiribosomal activity of these compounds is investigated with cell-free translation assays using both bacterial ribosomes and recombinant hybrid ribosomes carrying eukaryotic decoding A site cassettes. Compounds substituted with an equatorial hydroxyl or amino group in the newly formed ring are considerably more active than their axial diastereomers, lending strong support to crystallographically derived models of aminoglycoside-ribosome interactions. One such bicyclic compound carrying an equatorial hydroxyl group has activity equal to that of the parent yet displays better ribosomal selectivity, predictive of an enhanced therapeutic index. A paromomycin analog lacking the hydroxymethyl ring I side chain is considerably less active than the parent. Antibacterial activity against model Gram negative and Gram positive bacteria is reported for selected compounds, as is activity against ESKAPE pathogens and recombinant bacteria carrying specific resistance determinants. Analogues with a bicyclic ring I carrying equatorial amino or hydroxyl groups mimicking the bound side chains of neomycin and paromomycin, respectively, show excellent activity and, by virtue of their novel structure, retain this activity in strains that are insensitive to the parent compounds. |
Author | Böttger, Erik C Mandhapati, Appi Reddy Vasella, Andrea Shcherbakov, Dimitri Kato, Takayuki Hobbie, Sven N Crich, David Yang, Guanyu |
AuthorAffiliation | Department of Chemistry ETH Zurich Institute of Medical Microbiology Organic Chemistry Laboratory University of Zurich |
AuthorAffiliation_xml | – name: Department of Chemistry – name: Institute of Medical Microbiology – name: University of Zurich – name: Organic Chemistry Laboratory – name: ETH Zurich – name: a Department of Chemistry, Wayne State University, Detroit, MI 48202, USA – name: b Institute of Medical Microbiology, University of Zurich, 8006 Zurich, Switzerland – name: c Organic Chemistry Laboratory, ETH Zurich, 8093 Zurich, Switzerland |
Author_xml | – sequence: 1 givenname: Appi Reddy surname: Mandhapati fullname: Mandhapati, Appi Reddy organization: Department of Chemistry – sequence: 2 givenname: Guanyu surname: Yang fullname: Yang, Guanyu organization: Department of Chemistry – sequence: 3 givenname: Takayuki surname: Kato fullname: Kato, Takayuki organization: Department of Chemistry – sequence: 4 givenname: Dimitri surname: Shcherbakov fullname: Shcherbakov, Dimitri organization: University of Zurich – sequence: 5 givenname: Sven N surname: Hobbie fullname: Hobbie, Sven N organization: University of Zurich – sequence: 6 givenname: Andrea surname: Vasella fullname: Vasella, Andrea email: vasella@org.chem.ethz.ch organization: ETH Zurich – sequence: 7 givenname: Erik C surname: Böttger fullname: Böttger, Erik C email: boettger@imm.uzh.ch organization: University of Zurich – sequence: 8 givenname: David orcidid: 0000-0003-2400-0083 surname: Crich fullname: Crich, David email: dcrich@chem.wayne.edu organization: Department of Chemistry |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28892368$$D View this record in MEDLINE/PubMed |
BookMark | eNqNks9u1DAQxiNURLeFG2eUIxKk2E6cOByQli3QSpWotHC2HGe89Sqxt7ZD2VvfgTfhxuv0SXB2t-WPQHCyZ-b3ja2Z7yDZM9ZAkjzG6Agjgl8shfRHVYOqihb3kgmmBGUUk3IvmSCESFaxMt9PDrxfxrAgDD9I9gljNclLNkm-zYMbZBgcZK-FhzY9Bq8XJhWmTedrEy5i6FOr0unKiX4ttbm5_nIunO3tJkqnRnR2MYB_mZ72K-uCMBJGQZSmM2uUXgxOBG1jz7BJljfXX7Nz6_U2GR861kqBgyj0aQPhCsD8IKe9NnaDnaxbZz-v0zk4Df5hcl-JzsOj3XmYfHz75sPsJDt7_-50Nj3LRIFJyJgqqpIoaBpgslSYQKUYwZQxXOG2JUULkjKqCC1q1aqaQi3qukFtA0VRtzg_TF5t-66GpodWgglOdHzldC_cmluh-a8Voy_4wn7itCwqQuvY4OmugbOXcVCB99pL6DphwA6eE4zLGpGSkn-iuM4ZZixHVUSf_Pytu__crjYCz7bAFTRWeanH-d5hoxdwTlGejzcUafb_9EyHzUZndjAhSslWKp313oHicleP49Adx4iPRuWjUfnOqFH0_DfR7Vt_wXeDGZNLO7joOv9n9Dvs4vyD |
CitedBy_id | crossref_primary_10_1021_acs_joc_0c00910 crossref_primary_10_1021_acs_joc_7b02891 crossref_primary_10_1021_acs_orglett_9b04279 crossref_primary_10_1093_jac_dky546 crossref_primary_10_1002_chem_202400017 crossref_primary_10_1021_acs_chemrev_0c01214 crossref_primary_10_1021_acsinfecdis_3c00233 crossref_primary_10_1039_C8GC00814K crossref_primary_10_3390_antibiotics12010025 crossref_primary_10_1016_j_jgar_2020_12_006 crossref_primary_10_1002_cmdc_202200486 crossref_primary_10_1021_jacs_0c11106 crossref_primary_10_1016_j_bmc_2019_115121 crossref_primary_10_1021_acsinfecdis_8b00052 crossref_primary_10_1039_D0SC04595K crossref_primary_10_1021_acs_joc_0c00743 crossref_primary_10_1021_acsomega_3c09226 crossref_primary_10_1021_jacs_4c01233 crossref_primary_10_1021_acs_joc_9b01075 crossref_primary_10_1021_acs_joc_0c01836 crossref_primary_10_3390_molecules23020284 crossref_primary_10_1016_j_carres_2020_107984 crossref_primary_10_1021_acs_orglett_5c00168 crossref_primary_10_1016_j_carres_2021_108254 crossref_primary_10_1021_acsinfecdis_2c00557 crossref_primary_10_1073_pnas_2013315118 crossref_primary_10_1021_jacs_9b01693 crossref_primary_10_1021_acsmedchemlett_1c00349 crossref_primary_10_1039_D1MD00214G crossref_primary_10_1016_j_tet_2022_133112 |
Cites_doi | 10.1002/cbic.200900779 10.1021/ja0543144 10.1016/j.drup.2012.05.001 10.1128/AAC.00572-10 10.1016/S0040-4039(97)10599-8 10.1039/C5MD00429B 10.1073/pnas.0707265105 10.1021/jm700967e 10.1021/acs.jmedchem.6b00793 10.1002/cmdc.201402146 10.1523/JNEUROSCI.3430-12.2013 10.1038/ng0793-289 10.1073/pnas.1204073109 10.1128/AAC.03239-14 10.1007/978-3-7091-0215-2_20 10.1021/jo971046m 10.1172/JCI77424 10.1039/C5MD00384A 10.1021/ja00234a047 10.1021/ja050918w 10.1056/NEJMc0806397 10.1093/nar/gkm658 10.1039/C39860001570 10.1201/9780585407500.ch11 10.1021/jo00388a038 10.1586/eri.12.25 10.1016/j.bmc.2008.08.053 10.1021/acsinfecdis.5b00069 10.1021/jacs.5b02248 10.1039/C5MD00344J 10.1039/C4SC01626B 10.1002/hlca.200890167 10.7164/antibiotics.27.677 10.1128/AAC.47.8.2565-2571.2003 10.1039/c39830000939 10.1016/0022-2836(87)90349-4 10.1038/35030019 10.1016/S0040-4039(00)99857-5 10.1002/anie.201310843 10.1039/C39880001461 10.1016/S0022-2836(02)01452-3 10.1002/9780470149676.ch9 10.1038/nsmb.2994 10.1007/978-1-4614-1400-1_7 10.1186/1472-6815-7-5 10.1086/420742 10.1021/cb3005116 10.1002/cbic.200300657 10.1021/ja505964r 10.1039/C39870001462 10.1016/j.carres.2017.05.015 10.1073/pnas.0811258106 10.1093/nar/gki862 10.1155/2011/937861 10.1038/ncomms4112 10.1128/mBio.01827-14 10.1126/science.1176667 10.1128/AAC.43.5.1003 10.1086/518605 10.1002/hlca.200590240 10.1039/C4MD00119B 10.1080/07328309408011662 10.1021/jo00170a070 10.1056/NEJMc0806396 10.1093/jac/dkq408 10.1111/j.1445-5994.2011.02452.x 10.3987/S(N)-1978-01-0197 10.1016/j.heares.2013.01.006 10.1021/jo00874a003 10.1586/ERI.12.25 10.1039/c5md00429b 10.1039/c4sc01626b 10.1039/c5md00384a 10.1039/c4md00119b 10.1039/c5md00344j |
ContentType | Journal Article |
Copyright | Copyright © 2017 American Chemical Society |
Copyright_xml | – notice: Copyright © 2017 American Chemical Society |
DBID | AAYXX CITATION 17B 1KM BLEPL DTL EGQ GYRTJ CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 5PM |
DOI | 10.1021/jacs.7b07754 |
DatabaseName | CrossRef Web of Knowledge Index Chemicus Web of Science Core Collection Science Citation Index Expanded Web of Science Primary (SCIE, SSCI & AHCI) Web of Science - Science Citation Index Expanded - 2017 Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef Web of Science MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic Web of Science AGRICOLA |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 1KM name: Index Chemicus url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/woscc/search-with-editions?editions=WOS.IC sourceTypes: Enrichment Source Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry |
EISSN | 1520-5126 |
EndPage | 14619 |
ExternalDocumentID | PMC5647259 28892368 000413503300040 10_1021_jacs_7b07754 b039127859 |
Genre | Research Support, U.S. Gov't, Non-P.H.S Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: University of Zurich – fundername: Wayne State University – fundername: NSF; National Science Foundation (NSF) grantid: MRI-084043 – fundername: NIH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA grantid: AI123352 – fundername: NIAID NIH HHS grantid: R01 AI123352 |
GroupedDBID | - .K2 02 53G 55A 5GY 5RE 5VS 7~N 85S AABXI ABFLS ABMVS ABPPZ ABPTK ABUCX ABUFD ACGFS ACJ ACNCT ACS AEESW AENEX AETEA AFEFF ALMA_UNASSIGNED_HOLDINGS AQSVZ BAANH BKOMP CS3 DU5 DZ EBS ED ED~ EJD ET F5P GNL IH9 JG JG~ K2 LG6 P2P ROL RXW TAE TN5 UHB UI2 UKR UPT VF5 VG9 VQA W1F WH7 X XFK YZZ ZHY --- -DZ -ET -~X .DC 4.4 AAHBH AAYWT AAYXX ABBLG ABJNI ABLBI ABQRX ACBEA ACGFO ADHLV AGXLV AHDLI AHGAQ CITATION CUPRZ GGK IH2 XSW YQT ZCA ~02 17B 1KM BLEPL DTL GROUPED_WOS_SCIENCE_CITATION_INDEX_EXPANDED GROUPED_WOS_WEB_OF_SCIENCE CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 5PM |
ID | FETCH-LOGICAL-a412t-8f4762febbe8c6f12e7f821588171dd24dec585f2549fdf95e9a99b0dbe449d13 |
IEDL.DBID | ACS |
ISICitedReferencesCount | 32 |
ISICitedReferencesURI | https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=CitingArticles&UT=000413503300040 |
ISSN | 0002-7863 1520-5126 |
IngestDate | Tue Sep 30 16:45:37 EDT 2025 Tue Aug 05 10:44:31 EDT 2025 Fri Sep 05 05:13:53 EDT 2025 Mon Jul 21 06:05:43 EDT 2025 Mon Sep 01 07:45:18 EDT 2025 Fri Sep 26 20:26:57 EDT 2025 Wed Oct 01 04:01:38 EDT 2025 Thu Apr 24 22:50:51 EDT 2025 Thu Aug 27 13:42:08 EDT 2020 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 41 |
Keywords | RIBOSOMAL-RNA METHYLATION ANTIBACTERIAL ACTIVITY DRUG DISCOVERY A-SITE CRYSTAL-STRUCTURES BACTERIAL-RESISTANCE ACUTE TOXICITY MITOCHONDRIAL 1555A-GREATER-THAN-G MUTATION AMINOGLYCOSIDE ANTIBIOTICS CARBOXYLIC-ACIDS |
Language | English |
LinkModel | DirectLink |
LogoURL | https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg |
MergedId | FETCHMERGED-LOGICAL-a412t-8f4762febbe8c6f12e7f821588171dd24dec585f2549fdf95e9a99b0dbe449d13 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-2400-0083 0000-0002-9205-0384 |
PMID | 28892368 |
PQID | 1938188307 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | crossref_primary_10_1021_jacs_7b07754 acs_journals_10_1021_jacs_7b07754 proquest_miscellaneous_2116902652 pubmed_primary_28892368 webofscience_primary_000413503300040 proquest_miscellaneous_1938188307 crossref_citationtrail_10_1021_jacs_7b07754 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5647259 webofscience_primary_000413503300040CitationCount |
ProviderPackageCode | JG~ 55A AABXI GNL VF5 7~N ACJ VG9 W1F ACS AEESW AFEFF .K2 ABMVS ABUCX IH9 BAANH AQSVZ ED~ UI2 CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-10-18 |
PublicationDateYYYYMMDD | 2017-10-18 |
PublicationDate_xml | – month: 10 year: 2017 text: 2017-10-18 day: 18 |
PublicationDecade | 2010 |
PublicationPlace | WASHINGTON |
PublicationPlace_xml | – name: WASHINGTON – name: United States |
PublicationTitle | Journal of the American Chemical Society |
PublicationTitleAbbrev | J AM CHEM SOC |
PublicationTitleAlternate | J. Am. Chem. Soc |
PublicationYear | 2017 |
Publisher | American Chemical Society Amer Chemical Soc |
Publisher_xml | – name: American Chemical Society – name: Amer Chemical Soc |
References | ref9/cit9 ref45/cit45 ref3/cit3 ref27/cit27 ref63/cit63 ref56/cit56 ref16/cit16 ref52/cit52 ref23/cit23 ref8/cit8 ref31/cit31 ref59/cit59 ref2/cit2 ref77/cit77 ref34/cit34 ref71/cit71 ref37/cit37 ref20/cit20 ref48/cit48 ref60/cit60 ref74/cit74 ref17/cit17 ref10/cit10 ref35/cit35 ref53/cit53 ref19/cit19 ref42/cit42 ref46/cit46 ref49/cit49 ref13/cit13 ref61/cit61 ref75/cit75 ref24/cit24 ref38/cit38 Mingeot-Leclercq M.-P. (ref21/cit21) 1999; 43 ref50/cit50 ref64/cit64 ref54/cit54 ref6/cit6 ref36/cit36 ref18/cit18 ref65/cit65 ref11/cit11 ref25/cit25 ref29/cit29 ref72/cit72 ref76/cit76 ref32/cit32 ref39/cit39 ref14/cit14 ref57/cit57 ref5/cit5 ref51/cit51 ref43/cit43 ref28/cit28 ref68/cit68 ref26/cit26 ref55/cit55 ref73/cit73 ref69/cit69 ref12/cit12 ref15/cit15 ref62/cit62 ref66/cit66 ref41/cit41 ref58/cit58 ref22/cit22 ref33/cit33 ref30/cit30 ref47/cit47 ref1/cit1 Gualerzi C. O. (ref4/cit4) 2014 ref44/cit44 ref70/cit70 ref7/cit7 Hobbie, SN (WOS:000250683600018) 2007; 35 Carter, AP (WOS:000089390700037) 2000; 407 CRICH, D (WOS:A1988R183500013) 1988 Vandebona, H (WOS:000263028800028) 2009; 360 ANELLI, PL (WOS:A1987H814800038) 1987; 52 Akbergenov, R (WOS:000299455400020) 2011 Huth, ME (WOS:000348962700017) 2015; 125 Aggen, JB (WOS:000284155000017) 2010; 54 DESS, DB (WOS:A1983RP44600070) 1983; 48 Duggal, P (WOS:000210278000001) 2007; 7 Armstrong, ES (WOS:000303216800007) 2012 Wang, J. (000413503300040.73) 2007 Wright, PM (WOS:000340526400003) 2014; 53 Kato, T (WOS:000368464200004) 2015; 1 Chen, W (WOS:000340353500019) 2014; 5 Bacot-Davis, VR (WOS:000370707500008) 2016; 7 François, B (WOS:000232593700040) 2005; 33 FUJISAWA, K (WOS:A1974U169200005) 1974; 27 Mandhapati, AR (WOS:000341623300017) 2014; 9 Haddad, Jalal (BCI:BCI200300101283) 2001 Jiang, L (WOS:000071241100005) 1998; 39 Houghton, JL (WOS:000277725000003) 2010; 11 Perez-Fernandez, D (WOS:000331084400021) 2014; 5 Blount, KF (WOS:000230434200037) 2005; 127 Huth, M. E. (000413503300040.44) 2011 Kaul, M (WOS:000181698300007) 2003; 326 BEAUCLERK, AAD (WOS:A1987G208300008) 1987; 193 Noeske, J (WOS:000352317000013) 2015; 22 Garneau-Tsodikova, S (WOS:000370707500002) 2016; 7 Doi, Y (WOS:000247029700017) 2007; 45 OCONNOR, S (WOS:A1976BT92100003) 1976; 41 Chen, L (WOS:000259568500022) 2008; 16 Francis, SP (WOS:000314887200031) 2013; 33 MOOTOO, DR (WOS:A1986E719400008) 1986 Zhanel, GG (WOS:000303630700013) 2012; 10 Kato, T (WOS:000407665100003) 2017; 448 O'Shea, R (WOS:000255906300001) 2008; 51 Livermore, DM (WOS:000285417700005) 2011; 66 Becker, B (WOS:000314008000011) 2013; 8 Holdren, J. P. (000413503300040.41) 2014 Bastida, A (WOS:000234547700046) 2006; 128 Matsushita, T (WOS:000357062000037) 2015; 137 OKADA, K (WOS:A1988R625200047) 1988; 110 Talaska, A. E. (000413503300040.70) 2007 Peloquin, CA (WOS:000221477400005) 2004; 38 Meyer, M (WOS:000344158600072) 2014; 58 Hobbie, SN (WOS:000262092800058) 2008; 105 Matt, T (WOS:000306641100056) 2012; 109 Böttger, EC (WOS:000323094400002) 2013; 303 MOOTOO, DR (WOS:A1987K340800029) 1987 BARTON, DHR (WOS:A1983RF66000012) 1983 Chu, LL (WOS:000340079800017) 2014; 136 Hobbie, SN (WOS:000253846500015) 2008; 105 Avent, ML (WOS:000292103400002) 2011; 41 PREZANT, TR (WOS:A1993LJ84200018) 1993; 4 Kondo, J. (000413503300040.50) 2014 (000413503300040.1) 1982 Pathak, R (WOS:000233767500017) 2005; 88 Bitner-Glindzicz, M (WOS:000263028800027) 2009; 360 KECK, GE (WOS:A1984RY83500008) 1984; 25 Maianti, JP (WOS:000370707500017) 2016; 7 Hanessian, S (WOS:000344376400010) 2014; 5 DeMico, A (WOS:A1997XZ71900043) 1997; 62 Gualerzi, C. O. (000413503300040.34) 2014 ASAKO, T (WOS:A1978GN32100022) 1978; 11 Herzog, IM (WOS:000383111300021) 2016; 59 Galimand, M (WOS:000184449800027) 2003; 47 Fischbach, MA (WOS:000269382300030) 2009; 325 BOCK, K (WOS:A1994NL93200001) 1994; 13 Pathak, R (WOS:000259049900016) 2008; 91 Mingeot-Leclercq, MP (WOS:000080035100002) 1999; 43 Pfister, P (WOS:000185870900018) 2003; 4 (000413503300040.2) 2013 Wachino, J (WOS:000307417100001) 2012; 15 Duscha, S (WOS:000345459000061) 2014; 5 |
References_xml | – ident: ref7/cit7 doi: 10.1002/cbic.200900779 – ident: ref46/cit46 doi: 10.1021/ja0543144 – ident: ref76/cit76 doi: 10.1016/j.drup.2012.05.001 – ident: ref13/cit13 doi: 10.1128/AAC.00572-10 – ident: ref60/cit60 doi: 10.1016/S0040-4039(97)10599-8 – ident: ref15/cit15 doi: 10.1039/C5MD00429B – ident: ref68/cit68 doi: 10.1073/pnas.0707265105 – ident: ref10/cit10 doi: 10.1021/jm700967e – ident: ref33/cit33 doi: 10.1021/acs.jmedchem.6b00793 – ident: ref50/cit50 doi: 10.1002/cmdc.201402146 – ident: ref36/cit36 doi: 10.1523/JNEUROSCI.3430-12.2013 – ident: ref27/cit27 doi: 10.1038/ng0793-289 – ident: ref38/cit38 doi: 10.1073/pnas.1204073109 – ident: ref39/cit39 doi: 10.1128/AAC.03239-14 – ident: ref35/cit35 doi: 10.1007/978-3-7091-0215-2_20 – ident: ref53/cit53 doi: 10.1021/jo971046m – ident: ref26/cit26 doi: 10.1172/JCI77424 – ident: ref72/cit72 doi: 10.1039/C5MD00384A – ident: ref64/cit64 doi: 10.1021/ja00234a047 – ident: ref12/cit12 – ident: ref45/cit45 doi: 10.1021/ja050918w – ident: ref29/cit29 doi: 10.1056/NEJMc0806397 – ident: ref37/cit37 doi: 10.1093/nar/gkm658 – ident: ref55/cit55 doi: 10.1039/C39860001570 – ident: ref11/cit11 doi: 10.1201/9780585407500.ch11 – ident: ref61/cit61 doi: 10.1021/jo00388a038 – ident: ref14/cit14 doi: 10.1586/eri.12.25 – ident: ref19/cit19 doi: 10.1016/j.bmc.2008.08.053 – ident: ref71/cit71 doi: 10.1021/acsinfecdis.5b00069 – ident: ref43/cit43 doi: 10.1021/jacs.5b02248 – ident: ref6/cit6 doi: 10.1039/C5MD00344J – ident: ref48/cit48 doi: 10.1039/C4SC01626B – ident: ref52/cit52 doi: 10.1002/hlca.200890167 – ident: ref18/cit18 doi: 10.7164/antibiotics.27.677 – volume-title: Antibiotics: Targets, Mechanisms and Resistance year: 2014 ident: ref4/cit4 – ident: ref75/cit75 doi: 10.1128/AAC.47.8.2565-2571.2003 – ident: ref2/cit2 – ident: ref62/cit62 doi: 10.1039/c39830000939 – ident: ref73/cit73 doi: 10.1016/0022-2836(87)90349-4 – ident: ref30/cit30 doi: 10.1038/35030019 – ident: ref54/cit54 doi: 10.1016/S0040-4039(00)99857-5 – ident: ref5/cit5 doi: 10.1002/anie.201310843 – ident: ref59/cit59 – ident: ref32/cit32 – ident: ref63/cit63 doi: 10.1039/C39880001461 – ident: ref69/cit69 doi: 10.1016/S0022-2836(02)01452-3 – ident: ref16/cit16 doi: 10.1002/9780470149676.ch9 – ident: ref31/cit31 doi: 10.1038/nsmb.2994 – ident: ref9/cit9 doi: 10.1007/978-1-4614-1400-1_7 – ident: ref23/cit23 doi: 10.1186/1472-6815-7-5 – ident: ref24/cit24 doi: 10.1086/420742 – ident: ref8/cit8 doi: 10.1021/cb3005116 – ident: ref70/cit70 doi: 10.1002/cbic.200300657 – ident: ref65/cit65 doi: 10.1021/ja505964r – ident: ref1/cit1 – ident: ref56/cit56 doi: 10.1039/C39870001462 – ident: ref66/cit66 doi: 10.1016/j.carres.2017.05.015 – ident: ref34/cit34 doi: 10.1073/pnas.0811258106 – ident: ref47/cit47 doi: 10.1093/nar/gki862 – ident: ref25/cit25 doi: 10.1155/2011/937861 – ident: ref41/cit41 doi: 10.1038/ncomms4112 – ident: ref42/cit42 doi: 10.1128/mBio.01827-14 – ident: ref3/cit3 doi: 10.1126/science.1176667 – volume: 43 start-page: 1003 year: 1999 ident: ref21/cit21 publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.43.5.1003 – ident: ref74/cit74 doi: 10.1086/518605 – ident: ref51/cit51 doi: 10.1002/hlca.200590240 – ident: ref20/cit20 doi: 10.1039/C4MD00119B – ident: ref49/cit49 doi: 10.1080/07328309408011662 – ident: ref57/cit57 doi: 10.1021/jo00170a070 – ident: ref28/cit28 doi: 10.1056/NEJMc0806396 – ident: ref77/cit77 doi: 10.1093/jac/dkq408 – ident: ref22/cit22 doi: 10.1111/j.1445-5994.2011.02452.x – ident: ref44/cit44 doi: 10.3987/S(N)-1978-01-0197 – ident: ref17/cit17 doi: 10.1016/j.heares.2013.01.006 – ident: ref58/cit58 doi: 10.1021/jo00874a003 – volume: 88 start-page: 2967 year: 2005 ident: WOS:000233767500017 article-title: Design and synthesis of aminoglycoside antibiotics to selectively target 16S ribosomal RNA position 1408 publication-title: HELVETICA CHIMICA ACTA – volume: 193 start-page: 661 year: 1987 ident: WOS:A1987G208300008 article-title: SITES OF ACTION OF 2 RIBOSOMAL-RNA METHYLASES RESPONSIBLE FOR RESISTANCE TO AMINOGLYCOSIDES publication-title: JOURNAL OF MOLECULAR BIOLOGY – volume: 13 start-page: 513 year: 1994 ident: WOS:A1994NL93200001 article-title: A CONFORMATIONAL STUDY OF HYDROXYMETHYL GROUPS IN CARBOHYDRATES INVESTIGATED BY H-1-NMR SPECTROSCOPY publication-title: JOURNAL OF CARBOHYDRATE CHEMISTRY – volume: 35 start-page: 6086 year: 2007 ident: WOS:000250683600018 article-title: Engineering the rRNA decoding site of eukaryotic cytosolic ribosomes in bacteria publication-title: NUCLEIC ACIDS RESEARCH doi: 10.1093/nar/gkm658 – volume: 58 start-page: 6938 year: 2014 ident: WOS:000344158600072 article-title: In Vivo Efficacy of Apramycin in Murine Infection Models publication-title: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY doi: 10.1128/AAC.03239-14 – volume: 105 start-page: 20888 year: 2008 ident: WOS:000262092800058 article-title: Genetic analysis of interactions with eukaryotic rRNA identify the mitoribosome as target in aminoglycoside ototoxicity publication-title: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA doi: 10.1073/pnas.0811258106 – volume: 41 start-page: 2087 year: 1976 ident: WOS:A1976BT92100003 article-title: APRAMYCIN, A UNIQUE AMINOCYCLITOL ANTIBIOTIC publication-title: JOURNAL OF ORGANIC CHEMISTRY – volume: 38 start-page: 1538 year: 2004 ident: WOS:000221477400005 article-title: Aminoglycoside toxicity: Daily versus thrice-weekly dosing for treatment of mycobacterial diseases publication-title: CLINICAL INFECTIOUS DISEASES – volume: 41 start-page: 441 year: 2011 ident: WOS:000292103400002 article-title: Current use of aminoglycosides: indications, pharmacokinetics and monitoring for toxicity publication-title: INTERNAL MEDICINE JOURNAL doi: 10.1111/j.1445-5994.2011.02452.x – volume: 11 start-page: 880 year: 2010 ident: WOS:000277725000003 article-title: The Future of Aminoglycosides: The End or Renaissance? publication-title: CHEMBIOCHEM doi: 10.1002/cbic.200900779 – volume: 11 start-page: 197 year: 1978 ident: WOS:A1978GN32100022 article-title: CHEMICAL TRANSFORMATION OF 3'-CHLORO-3'-DEOXYAMINOGLYCOSIDES INTO NEW CYCLIC PSEUDO-TRISACCHARIDES publication-title: HETEROCYCLES – volume: 33 start-page: 5677 year: 2005 ident: WOS:000232593700040 article-title: Crystal structures of complexes between aminoglycosides and decoding A site oligonucleotides: role of the number of rings and positive charges in the specific binding leading to miscoding publication-title: NUCLEIC ACIDS RESEARCH doi: 10.1093/nar/gki862 – volume: 10 start-page: 459 year: 2012 ident: WOS:000303630700013 article-title: Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin publication-title: EXPERT REVIEW OF ANTI-INFECTIVE THERAPY doi: 10.1586/ERI.12.25 – volume: 45 start-page: 88 year: 2007 ident: WOS:000247029700017 article-title: 16S ribosomal RNA methylation: Emerging resistance mechanism against aminoglycosides publication-title: CLINICAL INFECTIOUS DISEASES doi: 10.1086/518605 – volume: 43 start-page: 1003 year: 1999 ident: WOS:000080035100002 article-title: Aminoglycosides: Nephrotoxicity publication-title: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY – volume: 91 start-page: 1533 year: 2008 ident: WOS:000259049900016 article-title: Synthesis and evaluation of paromomycin derivatives modified at C(4′) publication-title: HELVETICA CHIMICA ACTA – volume: 33 start-page: 3079 year: 2013 ident: WOS:000314887200031 article-title: A Novel Role of Cytosolic Protein Synthesis Inhibition in Aminoglycoside Ototoxicity publication-title: JOURNAL OF NEUROSCIENCE doi: 10.1523/JNEUROSCI.3430-12.2013 – volume: 25 start-page: 265 year: 1984 ident: WOS:A1984RY83500008 article-title: STEREOCONTROLLED ADDITIONS OF ALLYLTRI-NORMAL-BUTYL-STANNANE TO ALPHA-HYDROXYALDEHYDE DERIVATIVES - A USEFUL ROUTE TO MONOPROTECTED ERYTHRO OR THREO DIOLS publication-title: TETRAHEDRON LETTERS – volume: 7 start-page: ARTN 5 year: 2007 ident: WOS:000210278000001 article-title: Audiologic monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-up publication-title: BMC EAR NOSE AND THROAT DISORDERS doi: 10.1186/1472-6815-7-5 – volume: 4 start-page: 289 year: 1993 ident: WOS:A1993LJ84200018 article-title: MITOCHONDRIAL RIBOSOMAL-RNA MUTATION ASSOCIATED WITH BOTH ANTIBIOTIC-INDUCED AND NON-SYNDROMIC DEAFNESS publication-title: NATURE GENETICS – volume: 137 start-page: 7706 year: 2015 ident: WOS:000357062000037 article-title: Influence of 4′-O-Glycoside Constitution and Configuration on Ribosomal Selectivity of Paromomycin publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY doi: 10.1021/jacs.5b02248 – year: 2011 ident: 000413503300040.44 publication-title: Int. J. Otolaryngol – start-page: 249 year: 2011 ident: WOS:000299455400020 article-title: Decoding and deafness: Two sides of a coin publication-title: RIBOSOMES: STRUCTURE, FUNCTION, AND DYNAMICS – volume: 326 start-page: 1373 year: 2003 ident: WOS:000181698300007 article-title: Coupling of drug protonation to the specific binding of aminoglycosides to the A site of 16 S rRNA: Elucidation of the number of drug amino groups involved and their identities publication-title: JOURNAL OF MOLECULAR BIOLOGY doi: 10.1016/S0022-2836(02)01452-3 – start-page: 229 year: 2012 ident: WOS:000303216800007 article-title: Aminoglycosides publication-title: ANTIBIOTIC DISCOVERY AND DEVELOPMENT, VOLS 1 AND 2 doi: 10.1007/978-1-4614-1400-1_7 – volume: 39 start-page: 355 year: 1998 ident: WOS:000071241100005 article-title: Borane/Bu2BOTf:: A mild reagent for the regioselective reductive ring opening of benzylidene acetals in carbohydrates publication-title: TETRAHEDRON LETTERS – volume: 5 start-page: ARTN e01827-14 year: 2014 ident: WOS:000345459000061 article-title: Identification and Evaluation of Improved 4′-O-(Alkyl) 4,5-Disubstituted 2-Deoxystreptamines as Next-Generation Aminoglycoside Antibiotics publication-title: MBIO doi: 10.1128/mBio.01827-14 – start-page: 1462 year: 1987 ident: WOS:A1987K340800029 article-title: AN OXIDATIVE REDUCTIVE, NON-HYDROLYTIC PROCEDURE FOR UNRAVELING COMPLEX ACETALS (GLYCOSIDES) - A POSSIBLE CHEMICAL ROLE FOR THE EXOANOMERIC EFFECT publication-title: JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS – volume: 127 start-page: 9818 year: 2005 ident: WOS:000230434200037 article-title: Conformational constraint as a means for understanding RNA-aminoglycoside specificity publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY doi: 10.1021/ja050918w – volume: 109 start-page: 10984 year: 2012 ident: WOS:000306641100056 article-title: Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycin publication-title: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA doi: 10.1073/pnas.1204073109 – volume: 53 start-page: 8840 year: 2014 ident: WOS:000340526400003 article-title: The Evolving Role of Chemical Synthesis in Antibacterial Drug Discovery publication-title: ANGEWANDTE CHEMIE-INTERNATIONAL EDITION doi: 10.1002/anie.201310843 – volume: 15 start-page: 133 year: 2012 ident: WOS:000307417100001 article-title: Exogenously acquired 16S rRNA methyltransferases found in aminoglycoside-resistant pathogenic Gram-negative bacteria: An update publication-title: DRUG RESISTANCE UPDATES doi: 10.1016/j.drup.2012.05.001 – volume: 360 start-page: 640 year: 2009 ident: WOS:000263028800027 article-title: Prevalence of Mitochondrial 1555A>G Mutation in European Children publication-title: NEW ENGLAND JOURNAL OF MEDICINE – start-page: 939 year: 1983 ident: WOS:A1983RF66000012 article-title: NEW AND IMPROVED METHODS FOR THE RADICAL DECARBOXYLATION OF ACIDS publication-title: JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS – volume: 16 start-page: 8940 year: 2008 ident: WOS:000259568500022 article-title: Structure-toxicity relationship of aminoglycosides:: Correlation of 2′-amine basicity with acute toxicity in pseudo-disaccharide scaffolds publication-title: BIOORGANIC & MEDICINAL CHEMISTRY doi: 10.1016/j.bmc.2008.08.053 – year: 2014 ident: 000413503300040.34 publication-title: Antibiotics: Targets, Mechanisms and Resistance – start-page: 1 year: 2014 ident: 000413503300040.41 publication-title: Report to the President on Combatting Antibiotic Resistance – volume: 128 start-page: 100 year: 2006 ident: WOS:000234547700046 article-title: Exploring the use of conformationally locked aminoglycosides as a new strategy to overcome bacterial resistance publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY doi: 10.1021/ja0543144 – volume: 7 start-page: 170 year: 2016 ident: WOS:000370707500017 article-title: Structural hybridization of three aminoglycoside antibiotics yields a potent broad-spectrum bactericide that eludes bacterial resistance enzymes publication-title: MEDCHEMCOMM doi: 10.1039/c5md00429b – start-page: 353 year: 2001 ident: BCI:BCI200300101283 article-title: Methodologies in syntheses of aminoglycoside antibiotics. publication-title: Glycochemistry: Principles, synthesis, and applications – volume: 136 start-page: 10886 year: 2014 ident: WOS:000340079800017 article-title: Carboxylic Acids as A Traceless Activation Group for Conjugate Additions: A Three-Step Synthesis of (±)-Pregabalin publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY doi: 10.1021/ja505964r – volume: 66 start-page: 48 year: 2011 ident: WOS:000285417700005 article-title: Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates publication-title: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY doi: 10.1093/jac/dkq408 – start-page: 453 year: 2014 ident: 000413503300040.50 publication-title: Antibioitcs: Targets, Mechanisms and Resistance – volume: 5 start-page: 4621 year: 2014 ident: WOS:000344376400010 article-title: Synthesis, broad spectrum antibacterial activity, and X-ray co-crystal structure of the decoding bacterial ribosomal A-site with 4′-deoxy-4′-fluoro neomycin analogs publication-title: CHEMICAL SCIENCE doi: 10.1039/c4sc01626b – volume: 325 start-page: 1089 year: 2009 ident: WOS:000269382300030 article-title: Antibiotics for Emerging Pathogens publication-title: SCIENCE doi: 10.1126/science.1176667 – volume: 47 start-page: 2565 year: 2003 ident: WOS:000184449800027 article-title: Plasmid-mediated high-level resistance to aminoglycosides in Enterobacteriaceae due to 16S rRNA methylation publication-title: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY doi: 10.1128/AAC.47.8.2565-2571.2003 – volume: 407 start-page: 340 year: 2000 ident: WOS:000089390700037 article-title: Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics publication-title: NATURE – volume: 54 start-page: 4636 year: 2010 ident: WOS:000284155000017 article-title: Synthesis and Spectrum of the Neoglycoside ACHN-490 publication-title: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY doi: 10.1128/AAC.00572-10 – start-page: 1570 year: 1986 ident: WOS:A1986E719400008 article-title: REMOTE PARTICIPATION IN ELECTROPHILIC REACTIONS OF PROTECTED POLYOLS publication-title: JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS – start-page: 255 year: 2007 ident: 000413503300040.70 publication-title: Aminoglycoside Antibiotics: From Chemical Biology to Drug Discovery – volume: 59 start-page: 8008 year: 2016 ident: WOS:000383111300021 article-title: Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/acs.jmedchem.6b00793 – volume: 105 start-page: 3244 year: 2008 ident: WOS:000253846500015 article-title: Mitochondrial deafness alleles confer misreading of the genetic code publication-title: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA doi: 10.1073/pnas.0707265105 – volume: 22 start-page: 336 year: 2015 ident: WOS:000352317000013 article-title: High-resolution structure of the Escherichia coli ribosome publication-title: NATURE STRUCTURAL & MOLECULAR BIOLOGY doi: 10.1038/nsmb.2994 – volume: 52 start-page: 2559 year: 1987 ident: WOS:A1987H814800038 article-title: FAST AND SELECTIVE OXIDATION OF PRIMARY ALCOHOLS TO ALDEHYDES OR TO CARBOXYLIC-ACIDS AND OF SECONDARY ALCOHOLS TO KETONES MEDIATED BY OXOAMMONIUM SALTS UNDER 2-PHASE CONDITIONS publication-title: JOURNAL OF ORGANIC CHEMISTRY – volume: 8 start-page: 105 year: 2013 ident: WOS:000314008000011 article-title: Aminoglycoside Antibiotics in the 21st Century publication-title: ACS CHEMICAL BIOLOGY doi: 10.1021/cb3005116 – volume: 303 start-page: 12 year: 2013 ident: WOS:000323094400002 article-title: The mitochondrion: A perpetrator of acquired hearing loss publication-title: HEARING RESEARCH doi: 10.1016/j.heares.2013.01.006 – volume: 9 start-page: 2074 year: 2014 ident: WOS:000341623300017 article-title: Importance of the 6′-Hydroxy Group and Its Configuration for Apramycin Activity publication-title: CHEMMEDCHEM doi: 10.1002/cmdc.201402146 – start-page: 1461 year: 1988 ident: WOS:A1988R183500013 article-title: STEREOSELECTIVE FREE-RADICAL REACTIONS IN THE PREPARATION OF 2-DEOXY-BETA-D-GLUCOSIDES publication-title: JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS – volume: 7 start-page: 103 year: 2016 ident: WOS:000370707500008 article-title: Drug-target networks in aminoglycoside resistance: hierarchy of priority in structural drug design publication-title: MEDCHEMCOMM doi: 10.1039/c5md00384a – volume: 62 start-page: 6974 year: 1997 ident: WOS:A1997XZ71900043 article-title: A versatile and highly selective hypervalent iodine (III)/2,2,6,6-tetramethyl-1-piperidinyloxyl-mediated oxidation of alcohols to carbonyl compounds publication-title: JOURNAL OF ORGANIC CHEMISTRY – volume: 4 start-page: 1078 year: 2003 ident: WOS:000185870900018 article-title: The molecular basis for A-site mutations conferring aminoglycoside resistance:: Relationship between ribosomal susceptibility and X-ray crystal structures publication-title: CHEMBIOCHEM doi: 10.1002/cbic.200300657 – volume: 448 start-page: 10 year: 2017 ident: WOS:000407665100003 article-title: Stereospecific synthesis of methyl 2-amino-2-deoxy-(6S)-deuterio-α,β-D-glucopyranoside and methyl 2,6-diamino-2,6-dideoxy-(6R)deuterio-α,β-D-glucopyranoside: Side chain conformations of the 2amino-2-deoxy and 2,6-diamino-2,6-dideoxyglucopyranosides publication-title: CARBOHYDRATE RESEARCH doi: 10.1016/j.carres.2017.05.015 – volume: 125 start-page: 583 year: 2015 ident: WOS:000348962700017 article-title: Designer aminoglycosides prevent cochlear hair cell loss and hearing loss publication-title: JOURNAL OF CLINICAL INVESTIGATION doi: 10.1172/JCI77424 – volume: 360 start-page: 642 year: 2009 ident: WOS:000263028800028 article-title: Prevalence of Mitochondrial 1555A>G Mutation in Adults of European Descent publication-title: NEW ENGLAND JOURNAL OF MEDICINE – volume: 1 start-page: 479 year: 2015 ident: WOS:000368464200004 article-title: Synthesis and Antiribosomal Activities of 4′-Ο-, 6′-Ο-, 4"-Ο-, 4′,6′-Ο and 4",6"-Ο-Derivatives in the Kanamycin Series Indicate Differing Target Selectivity Patterns between the 4,5-and 4,6-Series of Disubstituted 2-Deoxystreptamine Aminoglycoside Antibiotics publication-title: ACS INFECTIOUS DISEASES doi: 10.1021/acsinfecdis.5b00069 – volume: 5 start-page: ARTN 3112 year: 2014 ident: WOS:000331084400021 article-title: 4′-O-substitutions determine selectivity of aminoglycoside antibiotics publication-title: NATURE COMMUNICATIONS doi: 10.1038/ncomms4112 – volume: 27 start-page: 677 year: 1974 ident: WOS:A1974U169200005 article-title: AMINOGLYCOSIDE ANTIBIOTICS .7. ACUTE TOXICITY OF AMINOGLYCOSIDE ANTIBIOTICS publication-title: JOURNAL OF ANTIBIOTICS – start-page: 141 year: 2007 ident: 000413503300040.73 publication-title: Aminoglycoside Antibiotics – volume: 48 start-page: 4155 year: 1983 ident: WOS:A1983RP44600070 article-title: READILY ACCESSIBLE 12-I-5 OXIDANT FOR THE CONVERSION OF PRIMARY AND SECONDARY ALCOHOLS TO ALDEHYDES AND KETONES publication-title: JOURNAL OF ORGANIC CHEMISTRY – start-page: 1 year: 2013 ident: 000413503300040.2 publication-title: Antibiotic Resistance Threats in the United States, 2013 – volume: 110 start-page: 8736 year: 1988 ident: WOS:A1988R625200047 article-title: A NEW AND PRACTICAL METHOD OF DECARBOXYLATION - PHOTOSENSITIZED DECARBOXYLATION OF N-ACYLOXYPHTHALIMIDES VIA ELECTRON-TRANSFER MECHANISM publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY – volume: 51 start-page: 2871 year: 2008 ident: WOS:000255906300001 article-title: Physicochemical properties of antibacterial compounds: Implications for drug discovery publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/jm700967e – year: 1982 ident: 000413503300040.1 publication-title: US Patent – volume: 5 start-page: 1179 year: 2014 ident: WOS:000340353500019 article-title: Synthesis, antiribosomal and antibacterial activity of 4′-O-glycopyranosyl paromomycin aminoglycoside antibiotics publication-title: MEDCHEMCOMM doi: 10.1039/c4md00119b – volume: 7 start-page: 11 year: 2016 ident: WOS:000370707500002 article-title: Mechanisms of resistance to aminoglycoside antibiotics: overview and perspectives publication-title: MEDCHEMCOMM doi: 10.1039/c5md00344j |
SSID | ssj0004281 |
Score | 2.4143677 |
Snippet | The preparation of a series of four analogues of the aminoglycoside antibiotics neomycin and paromomycin is described in which ring I, involved in critical... |
Source | Web of Science |
SourceID | pubmedcentral proquest pubmed webofscience crossref acs |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 14611 |
SubjectTerms | Anti-Bacterial Agents - chemical synthesis Anti-Bacterial Agents - chemistry antibacterial properties Chemistry Chemistry, Multidisciplinary diastereomers Gram-positive bacteria moieties Nebramycin - analogs & derivatives Nebramycin - chemical synthesis Nebramycin - chemistry neomycin Neomycin - analogs & derivatives Paromomycin - analogs & derivatives Paromomycin - chemical synthesis pathogens Physical Sciences ribosomes Ribosomes - metabolism Science & Technology therapeutics translation (genetics) |
Title | Structure-Based Design and Synthesis of Apramycin–Paromomycin Analogues: Importance of the Configuration at the 6′-Position and Differences between the 6′-Amino and Hydroxy Series |
URI | http://dx.doi.org/10.1021/jacs.7b07754 http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=FullRecord&UT=000413503300040 https://www.ncbi.nlm.nih.gov/pubmed/28892368 https://www.proquest.com/docview/1938188307 https://www.proquest.com/docview/2116902652 https://pubmed.ncbi.nlm.nih.gov/PMC5647259 |
Volume | 139 |
WOS | 000413503300040 |
WOSCitedRecordID | wos000413503300040 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVABC databaseName: American Chemical Society Journals customDbUrl: eissn: 1520-5126 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0004281 issn: 0002-7863 databaseCode: ACS dateStart: 18790101 isFulltext: true titleUrlDefault: https://pubs.acs.org/action/showPublications?display=journals providerName: American Chemical Society |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NbhMxELagHODC_89SQK5UTmij2Nkfm1tIKQEJVClU6i3yru2yarOpuptDOPUdeBNufZ0-CTNeb0JSInpLNmNtPB57vrHH3xCyG-mIW9FToYZgIIyU1KFSKg7jlFmYW5kSBjf0v35LhofRl6P4aJkgu36Cz5EfKK86aeao2m6TOzwRDIOs_mC0vP_IBWthbiqSnk9wX2-NDiivVh3QNVT57-TINYfknM_-A_KpvcLT5JycdGZ11sl_Xmd0_E-_HpL7Hn_SfmMwj8gtUz4mdwdt2bcn5HLkGGVn5yb8AB5O0z2X40FVqeloXgJerIqKTi3tn52ryTwvyquLXwcKs_rcN4o0J7gfVL2nnycO3UOHsAE0pXjBsDieNWZHVe0eJlcXv8MDnz3mXrTny7bAIkZ9JtlSsj8pyqkTG841aoTiFp-pnpLD_Y_fB8PQ13cIVcR4HQobwVJsTZYZkSeWcZNaARBEwAgzrXmkTQ7RjMUY1morYyOVlFlXZyaKpGa9Z2SrnJbmBaEWSWcA-lkMqKSRqNZEWFhCY2u7VgRkB9Q99vOzGrujdw6hDz71gxCQd61hjHNPkI51Ok43SL9dSJ81xCAb5HZaGxvDSOJxjCrNdAb_QSJaErDIbpaB8DyRECbHPCDPG7tcvI0LAeg8gb6lKxa7EEDm8NVfyuKHYxCPsWhALAOy-7dtLxrilGI9PODGT92AsJuIDbzOkEyhfnkDhW-TexxBEuYHiVdkC8zbvAaIV2dv3Pz-AyknUXA |
linkProvider | American Chemical Society |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NbhMxEB5BOZQL_5Tl15XKCW2V3eyPzS2kVCm0UaW0Um-Rd23DCrKpuptDOPUdeBNuvE6fhBnH2ZBApNwSZ5y1Z8eeb-zxZ4C9SEWh4W3pKwwG_EgK5UspYz9OA4NjK5Nc04L-ST_pnUefLuILd1idzsJgIyr8p8pu4i_YBYgmCAvTzDK23YY7lgSFkFB3sDgGGfJgjnZTnrRdnvtqbfJDebXsh_4Bl__PkVzxS9YHHd6HftN6m3rybX9SZ_v5jxVix4279wDuOTTKOjPzeQi3dPkItrvzS-Aew--B5ZedXGn_A_o7xQ5sxgeTpWKDaYnosSoqNjasc3klR9O8KG-uf55KyvGz3xiRntDqUPWeHY0s1sd-UQWsyui4YfFlMjNCJmtbmNxc__JPXS6ZfdCBu8QFpzTm8soWkp1RUY6tWG-qSDGMFvx09QTODz-edXu-u-3Bl1EQ1j43EU7MRmeZ5nliglCnhiMg4TxIA6XCSOkcYxtDEa1RRsRaSCGylsp0FAkVtJ_CVjku9TNghihoEAgaCq-EFqTWhBucUGNjWoZ7sIvqHrrRWg3tRnyIgRCVupfgwbu5fQxzR5dOt3Z8XyP9tpG-nNGErJHbnZvaEN8kbc7IUo8n2AZB2InjlLteBoP1RGDQHIce7MzMs3layDli9QT7li4ZbiNAPOLLv5TFV8snHtMVArHwYO9vE28q0sgK2rTdTZ9aHgSbiHWdzohaoX6-gcLfwHbv7OR4eHzU__wC7oYEnyhziL-ELTR1_QrBX529tkP-D-5NWds |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLbGkGAv3DfC1ZPGE8pUp7nYvJWWquMyVZRJe4uc2IYImlZL-lCe9h_4J7zxd_ZLOMd1M1qoNN5yOU5i5xz7O_bxdwg5CFUYGN6WvgJnwA-lUL6UMvKjhBmwrUxyjRP6H47jwUn49jQ63SJsuRcGPqKCJ1V2ER-teqqMYxhAqiC4kWSWte0auR4h-xuioe7ocitkwNkS8SY8brtY9_XSOBbl1epY9BfA_Hec5NrYZMeh_m3ysamBDT_5ejirs8P8-xq5439V8Q655VAp7SzU6C7Z0uU9crO7TAZ3n_waWZ7Z2Zn2X8O4p2jPRn5QWSo6mpeAIquiohNDO9MzOZ7nRXlx_mMoMdbPnlEkP8FZouoVPRpbzA91wwJQlOK2w-LzbKGMVNb2Ynxx_tMfupgy-6KeS-YCXRt18WWXkp1xUU6s2GCusHEoTvzp6gE56b_51B34LuuDL0MW1D43IXTQRmeZ5nlsWKATwwGYcM4SplQQKp2Dj2PQszXKiEgLKUTWUpkOQ6FYe5dsl5NSPyTUIBUNAEKDbpbQAps15gY61siYluEe2YfmTp3VVqldkA_AIcKr7id45OVSR9Lc0aZj9o5vG6RfNNLTBV3IBrn9pbql8CdxkUaWejKDbxCIoTh0vZtlwGmPBTjPUeCRvYWKNm8LOAfMHkPdkhXlbQSQT3z1Tll8sbziEaYSiIRHDv5U86YgWhdr47I3HrU8wq4i1nVthhQL9aMrNPhzcmPY66fvj47fPSY7AaIoDCDiT8g2aLp-Chiwzp5Zq_8NkU5cVQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Structure-Based+Design+and+Synthesis+of+Apramycin-Paromomycin+Analogues%3A+Importance+of+the+Configuration+at+the+6%E2%80%B2-Position+and+Differences+between+the+6%E2%80%B2-Amino+and+Hydroxy+Series&rft.jtitle=Journal+of+the+American+Chemical+Society&rft.au=Mandhapati%2C+Appi+Reddy&rft.au=Yang%2C+Guanyu&rft.au=Kato%2C+Takayuki&rft.au=Shcherbakov%2C+Dimitri&rft.date=2017-10-18&rft.pub=Amer+Chemical+Soc&rft.issn=0002-7863&rft.volume=139&rft.issue=41&rft.spage=14611&rft.epage=14619&rft_id=info:doi/10.1021%2Fjacs.7b07754&rft_id=info%3Apmid%2F28892368&rft.externalDBID=n%2Fa&rft.externalDocID=000413503300040 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-7863&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-7863&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-7863&client=summon |